Premature Ovarian Failure
Conditions
Interventions
treatment group:Bu Shen Huo Xue Fang
Sponsors
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
16 Years to 40 Years
Inclusion criteria
Inclusion criteria: (1) Women aged from 16 to 40 with normal development; (2) In line with the Western diagnostic criteria and irregular menstruation syndrome of kidney deficiency syndrome; (3) Did not receive hormone therapy for at least 3 months; (4) Those who are willing to participate in the study and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Those who are in the acute inflammatory phase or tumor disease using chemotherapy drugs; (2) Those who has the problem of genital tract malformations, gonadal dysgenesis and other organic diseases; (3) Patients with a history of bilateral ovariectomy; (4) Those who suffers from diabetes, cardiovascular, lung, liver, kidney and hematopoietic system and other serious primary disease, or other serious diseases affecting fertility; (5) Those who has mental illness, epilepsy, neurosis and other mental illness; (6) Those who has the test drug allergy or severe allergic constitution; (7) Those who is participating in other drug clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FSH;LH;E2;PRL;P;T;INHB;ACT;FS;FSHR;AMH;AOAb;AZP;ANA;AEA;ACA;IL-1;Ovarian volume;Number of antral follicles;peak systolic velocity;resistance index; | — |
Countries
China
Contacts
Public ContactLi Dong
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Outcome results
None listed